Ranolazine-induced Repolarization Changes: A Case Report

Am J Med. 2015 Jul;128(7):e3-5. doi: 10.1016/j.amjmed.2015.01.019. Epub 2015 Feb 3.

Authors

Anand Kumthekar¹, Francesca Cossarini¹, Julia C Shih¹, Cynthia C Taub², Daniele Massera³

Affiliations

¹ Department of Medicine, Jacobi Medical Center, Bronx, NY.
² Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
³ Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY. Electronic address: dmassera@montefiore.org.

PMID: 25660248
DOI: 10.1016/j.amjmed.2015.01.019

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acetanilides / adverse effects*
Acetanilides / therapeutic use
Action Potentials / drug effects
Chest Pain / diagnosis
Chest Pain / drug therapy
Coronary Angiography / methods
Coronary Restenosis / diagnostic imaging
Coronary Restenosis / drug therapy*
Coronary Stenosis / diagnostic imaging
Coronary Stenosis / therapy
Electrocardiography / drug effects*
Female
Follow-Up Studies
Heart Conduction System / drug effects
Humans
Long QT Syndrome / chemically induced*
Long QT Syndrome / diagnosis
Middle Aged
Piperazines / adverse effects*
Piperazines / therapeutic use
Ranolazine
Risk Assessment
Sodium Channel Blockers / adverse effects
Sodium Channel Blockers / therapeutic use
Stents
Takotsubo Cardiomyopathy / diagnosis
Takotsubo Cardiomyopathy / drug therapy*

Substances

Acetanilides
Piperazines
Sodium Channel Blockers
Ranolazine